Adaptyx develops aptamer-based wearable sensors for continuous biomarker monitoring, enabling real-time tracking of health markers to improve the management of chronic conditions like heart failure and diabetes.
About the company
Adaptyx is a healthtech company focused on addressing critical gaps in health monitoring through its aptamer-based wearable sensors. Spun out of Dr. Tom Soh’s lab at Stanford University, Adaptyx’s proprietary platform uses real-time, multi-biomarker tracking to provide actionable insights for managing chronic conditions like heart failure and diabetes.
With a strong patent portfolio and a team of experts in biosensing and healthcare technology, Adaptyx is strategically positioned to deliver cutting-edge solutions for both clinical and at-home care. By targeting high-impact use cases, Adaptyx aims to improve patient outcomes, reduce hospital readmissions, and expand access to precision health monitoring.
Why We Invested
Managing chronic conditions like heart failure and diabetes requires continuous health monitoring, yet current solutions rely on point-in-time tests that fail to capture dynamic biomarker changes. Adaptyx addresses this unmet need with an innovative aptamer-based platform that enables real-time, multi-biomarker tracking, offering transformative potential for improving patient outcomes and reducing hospital readmissions.
As healthcare increasingly shifts toward precision and preventative care, Adaptyx’s technology is well-positioned to lead in both clinical and at-home monitoring. With a strong foundation in Stanford research, a robust patent portfolio, and a clear regulatory pathway, Adaptyx is set up for scalable growth in a high-demand sector.